CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 170 enrolled
Drug / intervention
Delefilcon A multifocal contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02871375
NCT02871375N/ACompleted

DAILIES TOTAL1® Multifocal Clinical Assessment in Challenging Patients

Alcon, a Novartis Company·interventional·Posted Aug 18, 2016·Updated Jul 2, 2018

In Brief

A clinical study evaluating Delefilcon A multifocal contact lenses and Habitual multifocal contact lenses for Refractive Error. Completed, enrolled 170 participants.

Detailed Summary

The purpose of this study is to evaluate DAILIES TOTAL1® Multifocal (DTl MF) contact lenses in current multifocal contact lens wearers with symptoms of end of day discomfort compared to their habitual multifocal contact lens correction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 18, 2016
Enrollment StartAug 30, 2016
Primary CompletionNov 14, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.9 years ago

Interventions

Delefilcon A multifocal contact lensesdevice

Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)

Habitual multifocal contact lensesdevice

Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality